Avaxia Biologics

Developing orally-delivered antibody therapeutics for GI diseases.

placeLexington, Kentucky, United States calendar_todayFounded 2005 groups11 employees language avaxiabiologics.com

Registered entities

Innovation

8 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 529 times.

YearFilings
20125
20137
20147
20156
20161
20172
20191

Investor mix

20 investors on record; lead investors include Cherrystone Angel Group, Golden Seeds.

Investor typeCountShare
Venture capital315%
Angel & family office1155%
Accelerator & incubator15%
Other / undisclosed525%
Coming soon